Acquisition by Kayyem Jon Faiz of 18750 shares of Inhibrx at 14.1921 subject to Rule 16b-3

NSHD Index   708.00  1,142  61.73%   
About 55% of NYSE Declining's investor base is interested to short. The analysis of the overall investor sentiment regarding NYSE Declining Stocks suggests that many traders are impartial. NYSE Declining's investing sentiment overview a quick insight into current market opportunities from investing in NYSE Declining Stocks. Many technical investors use NYSE Declining Stocks index news signals to limit their universe of possible portfolio assets and to time the market correctly.
Filed transaction by Inhibrx Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Acquisition of 18750 common stock at 14.1921 of Inhibrx by Kayyem Jon Faiz on 20th of November 2024. This event was filed by Inhibrx with SEC on 2024-11-20. Statement of changes in beneficial ownership - SEC Form 4

NYSE Declining Stocks Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NYSE Declining index to make a market-neutral strategy. Peer analysis of NYSE Declining could also be used in its relative valuation, which is a method of valuing NYSE Declining by comparing valuation metrics with similar companies.